SEHK:2367Personal Products
Assessing Giant Biogene Holding’s Valuation As The Board Prepares 2025 Results And Potential Final Dividend
Board meeting puts Giant Biogene’s 2025 results and dividend plans in focus
Giant Biogene Holding (SEHK:2367) has called a board meeting for 19 March 2026 to approve its audited 2025 annual results and consider recommending a final dividend, a key calendar point for shareholders.
See our latest analysis for Giant Biogene Holding.
Despite a 2.49% 1 day share price return lifting the stock to HK$30.5, the 30 day share price return of 5.10% and 1 year total shareholder return of 54.97% decline...